Breakthrough zygomycosis and voriconazole
- PMID: 16170771
- DOI: 10.1086/444433
Breakthrough zygomycosis and voriconazole
Comment on
-
Zygomycosis in a tertiary-care cancer center in the era of Aspergillus-active antifungal therapy: a case-control observational study of 27 recent cases.J Infect Dis. 2005 Apr 15;191(8):1350-60. doi: 10.1086/428780. Epub 2005 Mar 16. J Infect Dis. 2005. PMID: 15776383
Similar articles
-
Breakthrough zygomycosis after voriconazole treatment in recipients of hematopoietic stem-cell transplants.N Engl J Med. 2004 Feb 26;350(9):950-2. doi: 10.1056/NEJM200402263500923. N Engl J Med. 2004. PMID: 14985500 No abstract available.
-
[Effect of new antifungals on the etiology of invasive fungal infections: emergence, resistance and breakthrough infection].Rev Esp Quimioter. 2006 Mar;19(1):11-3. Rev Esp Quimioter. 2006. PMID: 16688286 Spanish. No abstract available.
-
Invasive zygomycosis in hematopoietic stem cell transplant recipients receiving voriconazole prophylaxis.Clin Infect Dis. 2004 Aug 15;39(4):584-7. doi: 10.1086/422723. Epub 2004 Jul 30. Clin Infect Dis. 2004. PMID: 15356827
-
Voriconazole-associated zygomycosis: a significant consequence of evolving antifungal prophylaxis and immunosuppression practices?Clin Microbiol Infect. 2009 Oct;15 Suppl 5:93-7. doi: 10.1111/j.1469-0691.2009.02988.x. Clin Microbiol Infect. 2009. PMID: 19754766 Review.
-
Emerging importance of infections due to zygomycetes in organ transplant recipients.Int J Antimicrob Agents. 2008 Nov;32 Suppl 2:S115-8. doi: 10.1016/S0924-8579(08)70011-6. Int J Antimicrob Agents. 2008. PMID: 19013334 Review.
Cited by
-
In vitro activities of amphotericin B, caspofungin, itraconazole, posaconazole, and voriconazole against 45 clinical isolates of zygomycetes: comparison of CLSI M38-A, Sensititre YeastOne, and the Etest.Antimicrob Agents Chemother. 2007 Mar;51(3):1126-9. doi: 10.1128/AAC.01539-06. Epub 2006 Dec 28. Antimicrob Agents Chemother. 2007. PMID: 17194821 Free PMC article.
-
Recent developments in the management of invasive fungal infections in patients with oncohematological diseases.Ther Adv Hematol. 2016 Dec;7(6):345-359. doi: 10.1177/2040620716656381. Epub 2016 Jul 1. Ther Adv Hematol. 2016. PMID: 27904738 Free PMC article. Review.
-
Fungal infections of the CNS: treatment strategies for the immunocompromised patient.CNS Drugs. 2007;21(4):293-318. doi: 10.2165/00023210-200721040-00004. CNS Drugs. 2007. PMID: 17381184 Review.
-
Mucormycosis caused by unusual mucormycetes, non-Rhizopus, -Mucor, and -Lichtheimia species.Clin Microbiol Rev. 2011 Apr;24(2):411-45. doi: 10.1128/CMR.00056-10. Clin Microbiol Rev. 2011. PMID: 21482731 Free PMC article. Review.
-
Voriconazole : a review of its use in the management of invasive fungal infections.Drugs. 2007;67(2):269-98. doi: 10.2165/00003495-200767020-00009. Drugs. 2007. PMID: 17284090 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources